UNSPSC 51281718: Bacampicillin hydrochloride

This classification denotes a penicillin antibiotic with the molecular formula C21H27N3O7S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PM034U953T, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, 1-((ethoxycarbonyl)oxy)ethyl ester, monohydrochloride, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as bacampicillin hydrochloride, which bears US NIH Compound Identifier 71429.

UNSPSC 51281718 Bacampicillin hydrochloride, a Commodity code, shows little relevant recent activity under its nominal scope. The source contains four recent state and local solicitations tagged with this code, but only one—a Seminole County, Florida IFB for naloxone and drug deactivation systems—involves pharmaceutical procurement; the others address broader medical supply, pharmacy benefit program design, and cooperative purchasing frameworks for generic pharmaceuticals and OTC products that fall outside the specific antibiotic product line the code names. The single directly relevant opportunity, Seminole County's IFB 60459723LAS, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries, with a two-year initial term and one-year renewal option, but naloxone is an opioid antagonist used in emergency response, not a bacampicillin-class product. State and local buyers accessing this code appear to include county health departments, fire departments procuring medical consumables, state health agencies evaluating pharmacy benefit programs through cooperative purchasing alliances like MMCAP, and municipal purchasing offices managing emergency response supplies.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with MMCAP (the Minnesota Multistate Cooperative Purchasing Alliance, administered by the Minnesota Department of Administration) representing a multi-state purchasing vehicle that coordinates pharmaceutical procurement across member jurisdictions. The Seminole County IFB (response deadline July 26, 2023, posted June 30, 2026) requires electronic submission, compliance with E-Verify and drug-free workplace certification, and potentially includes FEMA funding with associated federal compliance obligations. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment models outside traditional pharmacy benefit manager arrangements. The City of Tampa's ITB 26P00145 for medical and first aid supplies supporting the Fire Department Rescue Division, due March 13, 2026, carries an estimated contract value of $700,000 and includes a 5% bid discount for certified Small Local Business Enterprises (SLBEs). The MMCAP RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, requires NDC-specific product data, cGMP and DSCSA compliance, and mandatory relationships with AmerisourceBergen, Cardinal Health, or Morris & Dickson wholesalers. The mismatch between the code's nominal scope and the solicitations shown suggests that state and local procurement systems may be applying this code broadly to pharmaceutical-related acquisitions rather than to bacampicillin specifically.